|
PTER expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.583810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.164800E-01 |
| Normal-vs-Stage2 |
1.988170E-01 |
| Normal-vs-Stage3 |
3.550000E-01 |
| Normal-vs-Stage4 |
3.954000E-04 |
| Stage1-vs-Stage2 |
4.002800E-01 |
| Stage1-vs-Stage3 |
4.422000E-01 |
| Stage1-vs-Stage4 |
2.958800E-04 |
| Stage2-vs-Stage3 |
8.397200E-01 |
| Stage2-vs-Stage4 |
1.922450E-02 |
| Stage3-vs-Stage4 |
2.267600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.900000E-02 |
| Normal-vs-AfricanAmerican |
2.502600E-01 |
| Normal-vs-Asian |
5.142400E-01 |
| Caucasian-vs-AfricanAmerican |
8.934600E-01 |
| Caucasian-vs-Asian |
3.736200E-01 |
| AfricanAmerican-vs-Asian |
3.912600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.717200E-01 |
| Normal-vs-Female |
1.448380E-02 |
| Male-vs-Female |
8.104400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.055810E-02 |
| Normal-vs-Extreme_Weight |
4.656000E-02 |
| Normal-vs-Obese |
9.364800E-01 |
| Normal-vs-Extreme_Obese |
3.484400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.555000E-01 |
| Normal_Weight-vs-Obese |
7.047800E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.725600E-02 |
| Extreme_Weight-vs-Obese |
2.003600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.483800E-01 |
| Obese-vs-Extreme_Obese |
2.988200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.187800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.955800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.018380E-01 |
| Normal-vs-Age(81-100Yrs) |
7.867800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.320800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.298800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.779050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.023600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.774960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.170200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.294400E-01 |
| Normal-VS-Type2 PRCC |
5.699400E-01 |
| Normal-VS-KIRP CIMP |
8.375800E-04 |
| Normal-VS-Unclassified PRCC |
6.690200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.300600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.296200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.220600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.553860E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.559400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.069610E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.245200E-01 |
| Normal-vs-N1 |
1.950450E-04 |
| Normal-vs-N2 |
1.080740E-03 |
| N0-vs-N1 |
1.340170E-02 |
| N0-vs-N2 |
3.837600E-04 |
| N1-vs-N2 |
1.559620E-01 |
|
|
